App-Based exercise may boost immune health in antibody deficiency

NCT ID NCT07698197

First seen Jul 13, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This study tests whether a 12-week, app-guided exercise program is safe and practical for adults with primary antibody deficiencies—conditions where the immune system struggles to fight infections. Researchers will track how many people join and finish the program, how often they exercise, and whether it improves quality of life or immune function. The goal is to see if exercise can be a helpful addition to standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
app-based exercise program
What this could lead to
If successful, this could show that regular exercise is a safe, practical way to improve quality of life and immune function in people with primary antibody deficiencies.
What could go wrong
This is a small feasibility study with only 20 participants, so results may not apply to everyone. The program requires consistent app use, which may be challenging for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IGG SUBCLASS DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Bridgeport Hospital

    RECRUITING

    Milford, Connecticut, 06460, United States

  • Yale New Haven Health

    RECRUITING

    North Haven, Connecticut, 06473, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.